Click Image to Enlarge
What is bronchiolitis?
Bronchiolitis is an infection of the lower respiratory tract that usually affects children under 2 years of age. There is swelling in the smaller airways or bronchioles of the lung, which blocks air in the smaller airways.
What causes bronchiolitis?
The most common cause of bronchiolitis is a virus, most frequently the respiratory syncytial virus (RSV). However, many other viruses have been involved, including:
It is rarely caused by bacteria, usually mycoplasma pneumoniae.
Initially, the virus causes an infection in the upper respiratory tract, and then spreads downward into the lower tract. The virus causes inflammation and even death of the cells inside the respiratory tract. This leads to blockage of airflow in and out of the child's lungs.
Facts about bronchiolitis
Bronchiolitis usually occurs in the winter and early spring.
The most common age group affected by bronchiolitis is children under 2 years of age.
The following risk factors increase the likelihood that a child will develop bronchiolitis:
What are the symptoms of bronchiolitis?
The following are the most common symptoms of bronchiolitis:
Common cold symptoms, including:
Changes in breathing patterns (the child may be breathing fast or hard; you may hear wheezing, or a high-pitched sound)
Decreased appetite (infants may not eat well)
The symptoms of bronchiolitis may look like other conditions or medical problems. Always consult your child's health care provider for a diagnosis.
How is bronchiolitis diagnosed?
Bronchiolitis is usually diagnosed solely on the history and physical exam of the child. In some cases, tests may be done to rule out other diseases, such as pneumonia or asthma such as:
Chest X-rays. A diagnostic test which uses invisible electromagnetic energy beams to produce images of internal tissues, bones, and organs onto film.
Blood tests/blood gases
Pulse oximetry. An oximeter is a small machine that measures the amount of oxygen in the blood. To obtain this measurement, a small sensor (like a Band-Aid) is taped onto a finger or toe. When the machine is on, a small red light can be seen in the sensor. The sensor is painless and the red light does not get hot.
Nasopharyngeal swab. This is done for respiratory syncytial virus (RSV) and other respiratory viruses. These tests yield rapid results for presence of RSV or other viruses.
Treatment for bronchiolitis
Most cases are mild and can be treated at home. Because there is no cure for the disease, the goal of treatment is to relieve symptoms. Antibiotics are ineffective in the treatment of bronchiolitis. Some infants, if they are having severe breathing problems, may be treated in the hospital. While in the hospital, treatment may include:
Intravenous (IV) fluids if your child is unable to drink well
Oxygen therapy and a ventilator may be needed
Frequent suctioning of your child's nose and mouth (to help get rid of thick secretions)
Breathing treatments, as ordered by your child's doctor
If your child's health care provider feels your child is stable enough to be treated at home, the following treatment may be recommended:
Increased fluid intake
Frequent suctioning (with a bulb syringe) of your child's nose and mouth (to help get rid of thick secretions) especially prior to feedings
Breathing treatments, as ordered by your child's health care provider
Medication to help open your child's airways. Always consult your child's doctor for advice before giving over-the-counter (OTC) cold and cough medicines to children younger than 6 years of age.
Acetaminophen (Children's or Infants' Tylenol) for fever, as ordered by your child's health care provider. Do not give a child aspirin, because this medication has been linked to Reye syndrome, a disease of the brain and liver.
Note: It is also important for parents to elevate the child's head while sleeping.
Prevention of bronchiolitis
The best way to prevent bronchiolitis is good hygiene, such as regular hand-washing. An injection may be given to help decrease the chances of getting respiratory syncytial virus (RSV). The medication is called palivizumab (Synagis) and recommended only for high-risk infants, including premature infants (age at birth less than 35 weeks) and infants with chronic lung disease during RSV season. Specific recommendations regarding who should receive this vaccine are made by the American Academy of Pediatrics and can be discussed with your child's health care provider.